{"text": ["Monday", "6/25", "Insider", "Buying", "Report:", "DOVA,", "ABBV"], "created_at": "2018-06-25 19:07:20"}
{"text": ["Monday", "6/25", "Insider", "Buying", "Report:", "DOVA,", "ABBV"], "created_at": "2018-06-25 19:07:20"}
{"text": ["The", "Zacks", "Analyst", "Blog", "Highlights:", "Procter", "&", "Gamble,", "AbbVie,", "IBM,", "McDonald's", "and", "General", "Electric"], "created_at": "2018-06-25 14:10:50"}
{"text": ["The", "Zacks", "Analyst", "Blog", "Highlights:", "Procter", "&", "Gamble,", "AbbVie,", "IBM,", "McDonald's", "and", "General", "Electric"], "created_at": "2018-06-25 14:10:50"}
{"text": ["IMBRUVICA\u00ae", "(ibrutinib)", "Supplemental", "New", "Drug", "Application", "Accepted", "for", "Review", "by", "U.S.", "FDA", "with", "Potential", "to", "Broaden", "Treatment", "Use", "as", "a", "Combination", "Treatment", "Option", "with", "Rituximab", "in", "Waldenstr\u00f6m's", "Macroglobulinemia", "(WM),", "A", "Rare", "Form", "of", "Blood", "Cancer"], "created_at": "2018-06-25 13:00:00"}
{"text": ["The", "Zacks", "Analyst", "Blog", "Highlights:", "Procter", "&", "Gamble,", "AbbVie,", "IBM,", "McDonald&apos;s", "and", "General", "Electric"], "created_at": "2018-06-25 12:44:12"}
{"text": ["AbbVie", "and", "Calibr", "announce", "collaboration", "for", "next", "generation", "T-cell", "therapies"], "created_at": "2018-06-25 11:00:00"}
